Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3) - European Medical Journal

Prof John Gribben and Prof Andre Goy at ASH 2014: Treating mantle cell lymphoma (Part 3)

Hematology

Prof John Gribben (Barts Cancer Institute, London, UK) interviews Prof Andre Goy (John Theurer Cancer Center, Hackensack, NJ) at the 2014 American Society of Hematology (ASH) Annual Meeting about maintenance therapy with rituximab for the management of patients with mantle cell lymphoma.

This programme has been supported by sponsorship from Celgene.

Rate this content's potential impact on patient outcomes

Thank you!

Please share some more information on the rating you have given